Clinical Trials Logo

Filter by:
NCT ID: NCT02414919 Completed - Pregnancy Clinical Trials

Duration of Use of Highly Effective Reversible Contraception

Start date: April 1, 2015
Phase: N/A
Study type: Observational

To assess the proportion of women who use HERC for ≥2 years of duration

NCT ID: NCT02418390 Completed - Clinical trials for Thyroid Cancer, Papillary

The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma.

NCT ID: NCT02421627 Completed - Clinical trials for Irritable Bowel Syndrome

Moxibustion for Diarrhea-predominant Irritable Bowel Syndrome

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

To observe the safety and efficacy of moxibustion on diarrhea-predominant irritable bowel syndrome and evaluation by Magnetic Resonance Imaging (MRI), Event related potential (ERP).

NCT ID: NCT02426138 Completed - Diabetes Clinical Trials

Community Servings: Food as Medicine for Diabetes

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

Food insecurity, defined as difficulty accessing food owing to cost, affects 1 in 5 diabetes patients. To address this, the investigators are conducting a pilot randomized controlled trial of medically tailored meal delivery (MTM). The pilot study has two specific aims: Aim 1: To determine the effect of receiving MTM on dietary quality for food insecure diabetes patients with hyperglycemia Aim 2: To determine the feasibility and acceptability of the program as a medical intervention and refine the program as needed for testing in larger studies. This study is a crossover randomized controlled pilot trial, where approximately 50 participants, 25 in each arm, will be randomized to receipt of 12 weeks of MTM, to begin immediately, or waitlist control. After 12 weeks, the groups will crossover, with the waitlist control group now receiving 12 weeks of MTM. At baseline, 12 weeks, and 24 weeks, the participants will complete assessments of their dietary quality (HEI score), psychosocial measures such as diabetes distress and food insecurity, along with measures of body mass index, blood pressure, hemoglobin A1c, and lipids.

NCT ID: NCT02434042 Completed - Healthy Volunteers Clinical Trials

Effects of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses in Children

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

This project aims to study the benefits of probiotics namely Bifidobacterium longum BB536 in prevention of acute diarrhea and/or respiratory-related illnesses, which are found common among children in Malaysia aged from 2 to 6 years.

NCT ID: NCT02434705 Completed - Clinical trials for Eosinophilic Esophagitis

Food Antigen in Eosinophilic Esophagitis

EoE
Start date: April 1, 2015
Phase:
Study type: Observational

The relationship or effect of food antigen (wheat based soy sauce) in eosinophilic esophagitis. It is believed that when food antigens are exposed to the esophageal tissue it starts an chronic allergy-based inflammation. This will be analyzed with the esophageal biopsies and the mucosal impedance probe.

NCT ID: NCT02448316 Completed - Plantar Fasciitis Clinical Trials

Plantar Fasciitis, Operation or Conservative Treatment

Start date: April 1, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare in a randomized controlled trial the effect of endoscopic operation with the standard conservative treatmentprotocol with training supplemented with 1-3 injections of glucocorticoids in patients with chronic plantar fasciopathia.

NCT ID: NCT02481986 Completed - Asthma Clinical Trials

Asthma Action at Erie Trial

Start date: April 1, 2015
Phase: Phase 3
Study type: Interventional

The Asthma Action at Erie Trial compares the current best practice in asthma self-management education (certified asthma educator services) to an integrated community health worker (CHW) home intervention in which the real-life challenges of patients and the health care system are taken fully into account. This trial will provide clarity as to the expected effect size, cost savings, and resources needed to integrate asthma CHWs into clinical practice.

NCT ID: NCT02488824 Completed - Clinical trials for Mild Cognitive Impairment

Effect of Heat Exposure on Cognition in Persons With Tetraplegia

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

The ability to maintain normal body temperature (Tcore) is impaired in persons with tetraplegia: subnormal Tcore and vulnerability to hypothermia (<95 F) have been documented in this population after exposure to even mild environmental temperatures. However, no work to date has addressed the effect of subnormal Tcore on cognitive performance in persons with tetraplegia despite studies with able-bodied (AB) individuals that have documented progressive decline in various aspects of cognitive performance associated with the magnitude of the depression in Tcore. The investigators' study will confirm and extend their initial observations in persons with higher cord lesions who have subnormal Tcore to show that cognitive performance will be improved by raising Tcore to euthermic levels. This improvement should be associated with greater function and independence, reintegration into society, and an improved quality of life. Specific Aims: During exposure to 95 F for up to 120 minutes in the seated position, the investigators' aims are: Primary Specific Aim: To determine if a modest rise in Tcore to euthermic levels has a positive effect on cognitive performance (attention, working memory, processing speed, and executive function) in persons with higher-level spinal cord injury (SCI). Primary Hypothesis: Based on the investigators' pilot data: (1) 80% of persons with SCI will demonstrate an increase of 1 F in Tcore, while none of the AB controls will demonstrate such an increase; (2) 80% of persons with SCI will have an improvement of at least one T-score in Stroop Interference scores (a validated measure of executive function), while none of the AB controls will demonstrate a change in cognitive performance. Secondary Specific Aim: To determine changes in: (1) The average of distal skin temperatures; (2) Sweat rate; and (3) Subjective rating of thermal sensitivity. Secondary Hypothesis: Persons with SCI will have less of a percent change in average distal skin temperatures and sweat rate, and will report blunted ratings of thermal sensitivity compared to that of AB controls.

NCT ID: NCT02490033 Completed - Atrial Flutter Clinical Trials

The VERISMART Trial

VERISMART
Start date: April 1, 2015
Phase: N/A
Study type: Interventional

Catheter ablation is now routinely used in the management of heart rhythm disorders. One of the problems with the approach is that it has not been possible to determine whether the ablation catheter is in direct contact with the heart tissue or not. This is important because too much contact has safety implications and too little means that the therapy will be ineffective. Recently two different technologies have been developed to determine contact. Currently it is not know if one is superior to the other, and the objective of this trial is to determine whether there is a difference when treating a rhythm called atrial flutter.